FIRST PATIENTS ENROLLED INTO A LUNG CANCER STUDYOCT enrolled the first subjects into a Phase I study in patients diagnosed with stage IV non-small cell lung cancer with high (>50%) PD-L1 expression.
Despite an expectedly high patient screen-failure rate, OCT team managed to initiate the enrollment at a good pace with minimum screen failures.
As the enrollment of the non-small cell lung cancer patients is in progress, the company is planning to start recruiting patients with other types of cancer such as colorectal cancer and endometrial cancer.
Within this project, OCT is responsible for a wide range of services including project management, clinical and medical monitoring, regulatory support and logistics. Back to the list